Annovis Bio Inc.

NYSE: ANVS · Real-Time Price · USD
2.73
0.01 (0.37%)
At close: Aug 15, 2025, 3:59 PM
2.72
-0.37%
After-hours: Aug 15, 2025, 05:59 PM EDT

Annovis Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
17.13B 22.24M 10.55M 12.64M 4M 3.14M 5.75M 6.35M 15.72M 16.76M 28.38M 31.99M 35.97M 42.67M 45.69M 47.46M 49.22M 5.6M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Receivables
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
n/a -175 7.5K n/a n/a 5.8K 20.8K 20.62K 26.02K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Assets
17.13B 26.74M 13.93M 14.36M 5.05M 7.81M 10.21M 10.22M 22.82M 25.55M 36.02M 32.49M 36.53M 43.3M 46M 47.65M 49.5M 5.96M
Property-Plant & Equipment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Assets
21.45B 26.74M 13.93M 14.36M 5.05M 7.81M 10.21M 10.22M 22.82M 25.55M 36.02M 32.49M 36.53M 43.3M 46M 47.65M 49.5M 5.96M
Account Payables
974.31M 1.37M 2.31M 4.1M 3.39M 4.11M 1.29M 1.93M 1.17M 4.15M 3.96M 1.85M 901.84K 929K 688.07K 289.74K 114.83K 824.57K
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
2.81B 844.32K 1.21M -38 275.25K 499.07K 2.89M 1.24M 640.68K 1.13M 3.18M 209.13K 149.61K 158.92K n/a 587.17K 380.81K 379.23K
Total Current Liabilities
2.81B 2.5M 3.88M 5.39M 4.06M 4.87M 4.28M 3.56M 2.07M 5.41M 7.7M 2.53M 1.3M 1.26M 1.51M 1.12M 884.08K 1.6M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
319M 179K 737K 1.91M 2.74M 6.3M 13.68M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
319M 179K 737K 1.91M 2.74M 6.3M 13.68M n/a n/a 4.15B 3.96M 1.85M 901.84K 929K 688.07K n/a n/a n/a
Total Liabilities
3.12B 2.68M 4.62M 7.3M 6.8M 11.17M 17.96M 3.56M 2.07M 5.41M 7.7M 2.53M 1.3M 1.26M 1.51M 1.12M 884.08K 1.6M
Total Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock
1.95M 1.95K 1.41K 1.33K 1.17K 1.1K 1.05K 902.00 902.00 822.00 816.00 816.00 816.00 816.00 810.00 810.00 809.00 695.00
Retained Earnings
-146.61B -140.39M -134.85M -128.98M -116.35M -111.33M -110.26M -88.05M -73.33M -63.79M -54.05M -50.96M -43.34M -34.62M -28.73M -22.81M -19.96M -17.44M
Comprehensive Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 0.00 n/a 0.00 n/a 0.00 n/a 0.00 n/a
Shareholders Equity
18.33B 24.05M 9.31M 7.06M -1.75M -3.35M -7.75M 6.66M 20.74M 20.14M 28.32M 29.96M 35.23M 42.04M 44.49M 46.53M 48.61M 4.37M
Total Investments
n/a n/a n/a 12.62B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a